Dr. Boylan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4500 San Pablo Rd S
Jacksonville, FL 32224Phone+1 904-953-2000
Education & Training
University of California (San Francisco)Residency, Neurology, 1987 - 1990- University of California San Francisco School of MedicineClass of 1983
Johns Hopkins UniversityFellowship, Neuromuscular Medicine (Neurology)
Certifications & Licensure
FL State Medical License 1991 - 2019- American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- 8 citationsOld age amyotrophic lateral sclerosis and limbic TDP-43 pathology.Aya Murakami, Shunsuke Koga, Hiroaki Sekiya, Björn Oskarsson, Kevin Boylan
Brain Pathology. 2022-11-01 - 27 citationsAmyotrophic lateral sclerosis–specific quality of life–short form (ALSSQOL‐SF): A brief, reliable, and valid version of the ALSSQOL‐RStephanie H. Felgoise, Richard A. Feinberg, Helen E. Stephens, Paul E. Barkhaus, Kevin B. Boylan
Muscle & Nerve. 2018-11-01 - 208 citationsGenome-wide Analyses Identify KIF5A as a Novel ALS Gene.Aude Nicolas, Kevin P. Kenna, Alan E. Renton, Nicola Ticozzi, Faraz Faghri
Neuron. 2018-03-21
Press Mentions
Toward Clinical Trials for One Type of ALSJanuary 2nd, 2019
Gene Responsible for ALS and FTD Can Be Targeted with New Drug; Researchers Discover Biomarker to Track Disease ProgressionAugust 14th, 2014
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
